Annual Net Income
-$127.17 M
-$5.34 M-4.38%
December 31, 2024
Summary
- As of March 13, 2025, PRLD annual net profit is -$127.17 million, with the most recent change of -$5.34 million (-4.38%) on December 31, 2024.
- During the last 3 years, PRLD annual net income has fallen by -$15.48 million (-13.86%).
- PRLD annual net income is now -766.30% below its all-time high of -$14.68 million, reached on December 31, 2018.
Performance
PRLD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$28.73 M
+$3.54 M+10.97%
December 31, 2024
Summary
- As of March 13, 2025, PRLD quarterly net profit is -$28.73 million, with the most recent change of +$3.54 million (+10.97%) on December 31, 2024.
- Over the past year, PRLD quarterly net income has increased by +$3.54 million (+10.97%).
- PRLD quarterly net income is now -326.66% below its all-time high of -$6.73 million, reached on September 30, 2019.
Performance
PRLD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$127.17 M
+$4.34 M+3.30%
December 31, 2024
Summary
- As of March 13, 2025, PRLD TTM net profit is -$127.17 million, with the most recent change of +$4.34 million (+3.30%) on December 31, 2024.
- Over the past year, PRLD TTM net income has increased by +$4.34 million (+3.30%).
- PRLD TTM net income is now -1788.52% below its all-time high of -$6.73 million, reached on September 30, 2019.
Performance
PRLD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PRLD Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.4% | +11.0% | +3.3% |
| 3 y3 years | -13.9% | -0.3% | -10.2% |
| 5 y5 years | -361.3% | -0.3% | -10.2% |
PRLD Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.9% | at low | -5.0% | +17.3% | -13.9% | +3.3% |
| 5 y | 5-year | -361.3% | at low | -202.1% | +17.3% | -658.2% | +3.3% |
| alltime | all time | -766.3% | at low | -326.7% | +17.3% | -1788.5% | +3.3% |
Prelude Therapeutics Incorporated Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$127.17 M(+4.4%) | -$28.73 M(-11.0%) | -$127.17 M(-3.3%) |
| Sep 2024 | - | -$32.27 M(-7.1%) | -$131.52 M(+1.3%) |
| Jun 2024 | - | -$34.74 M(+10.5%) | -$129.85 M(+3.4%) |
| Mar 2024 | - | -$31.43 M(-5.0%) | -$125.55 M(+3.0%) |
| Dec 2023 | -$121.83 M(+5.5%) | -$33.08 M(+8.1%) | -$121.83 M(+3.8%) |
| Sep 2023 | - | -$30.61 M(+0.6%) | -$117.40 M(+0.6%) |
| Jun 2023 | - | -$30.43 M(+9.8%) | -$116.75 M(+2.7%) |
| Mar 2023 | - | -$27.72 M(-3.2%) | -$113.69 M(-1.5%) |
| Dec 2022 | -$115.44 M | -$28.64 M(-4.4%) | -$115.44 M(-3.5%) |
| Sep 2022 | - | -$29.96 M(+9.4%) | -$119.64 M(-0.6%) |
| Jun 2022 | - | -$27.37 M(-7.1%) | -$120.37 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$29.46 M(-10.3%) | -$119.86 M(+7.3%) |
| Dec 2021 | -$111.69 M(+96.2%) | -$32.84 M(+7.0%) | -$111.69 M(+13.9%) |
| Sep 2021 | - | -$30.69 M(+14.2%) | -$98.10 M(+16.5%) |
| Jun 2021 | - | -$26.86 M(+26.1%) | -$84.17 M(+22.5%) |
| Mar 2021 | - | -$21.30 M(+10.6%) | -$68.72 M(+20.7%) |
| Dec 2020 | -$56.93 M(+106.5%) | -$19.25 M(+14.9%) | -$56.93 M(+19.3%) |
| Sep 2020 | - | -$16.76 M(+46.9%) | -$47.72 M(+26.6%) |
| Jun 2020 | - | -$11.41 M(+19.9%) | -$37.69 M(+43.4%) |
| Mar 2020 | - | -$9.51 M(-5.3%) | -$26.28 M(+56.7%) |
| Dec 2019 | -$27.57 M(+87.8%) | -$10.04 M(+49.1%) | -$16.77 M(+149.1%) |
| Sep 2019 | - | -$6.73 M | -$6.73 M |
| Dec 2018 | -$14.68 M | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual net profit?
- What is the all time high annual net income for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual net income year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly net profit?
- What is the all time high quarterly net income for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly net income year-on-year change?
- What is Prelude Therapeutics Incorporated TTM net profit?
- What is the all time high TTM net income for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM net income year-on-year change?
What is Prelude Therapeutics Incorporated annual net profit?
The current annual net income of PRLD is -$127.17 M
What is the all time high annual net income for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual net profit is -$14.68 M
What is Prelude Therapeutics Incorporated annual net income year-on-year change?
Over the past year, PRLD annual net profit has changed by -$5.34 M (-4.38%)
What is Prelude Therapeutics Incorporated quarterly net profit?
The current quarterly net income of PRLD is -$28.73 M
What is the all time high quarterly net income for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly net profit is -$6.73 M
What is Prelude Therapeutics Incorporated quarterly net income year-on-year change?
Over the past year, PRLD quarterly net profit has changed by +$3.54 M (+10.97%)
What is Prelude Therapeutics Incorporated TTM net profit?
The current TTM net income of PRLD is -$127.17 M
What is the all time high TTM net income for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM net profit is -$6.73 M
What is Prelude Therapeutics Incorporated TTM net income year-on-year change?
Over the past year, PRLD TTM net profit has changed by +$4.34 M (+3.30%)